series-c-plus
Stage
2
Investors
About
Ardelyx is a biopharmaceutical company developing novel medicines focused on treating chronic kidney disease with hyperphosphatemia and gastrointestinal disorders such as irritable bowel syndrome with constipation (IBS-C).
Explore ARDELYX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.